FI851271L - Acyltripeptid-immunostimulanser. - Google Patents
Acyltripeptid-immunostimulanser.Info
- Publication number
- FI851271L FI851271L FI851271A FI851271A FI851271L FI 851271 L FI851271 L FI 851271L FI 851271 A FI851271 A FI 851271A FI 851271 A FI851271 A FI 851271A FI 851271 L FI851271 L FI 851271L
- Authority
- FI
- Finland
- Prior art keywords
- immunostimulanser
- acyltripeptid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/595,169 US4565653A (en) | 1984-03-30 | 1984-03-30 | Acyltripeptide immunostimulants |
Publications (2)
Publication Number | Publication Date |
---|---|
FI851271A0 FI851271A0 (fi) | 1985-03-29 |
FI851271L true FI851271L (fi) | 1985-10-01 |
Family
ID=24382038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI851271A FI851271L (fi) | 1984-03-30 | 1985-03-29 | Acyltripeptid-immunostimulanser. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4565653A (fi) |
EP (1) | EP0157572A3 (fi) |
JP (1) | JPS60224699A (fi) |
KR (1) | KR870000372B1 (fi) |
AU (2) | AU552919B2 (fi) |
CA (1) | CA1270098A (fi) |
DD (1) | DD239406A5 (fi) |
DK (1) | DK142485A (fi) |
EG (1) | EG17928A (fi) |
ES (1) | ES8605821A1 (fi) |
FI (1) | FI851271L (fi) |
GR (1) | GR850783B (fi) |
HU (1) | HU198086B (fi) |
IL (1) | IL74758A (fi) |
NO (1) | NO851278L (fi) |
NZ (1) | NZ211634A (fi) |
PH (1) | PH21303A (fi) |
PL (1) | PL252659A1 (fi) |
PT (1) | PT80181B (fi) |
ZA (1) | ZA852335B (fi) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1295784C (en) * | 1985-11-25 | 1992-02-11 | James Patrick Rizzi | Peptide immunostimulants |
JPH0718039B2 (ja) * | 1986-03-26 | 1995-03-01 | 株式会社豊田自動織機製作所 | 粉末付加亜鉛めっき鋼板の製造方法 |
WO1988001613A1 (en) * | 1986-08-27 | 1988-03-10 | Pfizer Inc. | Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor |
WO1988001612A1 (en) * | 1986-08-27 | 1988-03-10 | Pfizer Inc. | Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine |
DE3700173A1 (de) * | 1987-01-05 | 1988-07-14 | Hoechst Ag | Verfahren zur herstellung von lipophilen aminosaeurederivaten sowie lipophile aminosaeurederivate |
DE3820528A1 (de) * | 1988-06-16 | 1989-12-21 | Bayer Ag | Mittel zur insekten- und milbenabwehr |
US5185464A (en) * | 1989-02-21 | 1993-02-09 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5248820A (en) * | 1989-02-21 | 1993-09-28 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5136020A (en) * | 1989-02-21 | 1992-08-04 | Pfizer Inc. | Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5245079A (en) * | 1989-02-21 | 1993-09-14 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine |
US5134225A (en) * | 1989-02-21 | 1992-07-28 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine |
US5798387A (en) * | 1992-10-15 | 1998-08-25 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Amino acid derivatives |
EP0617009B1 (en) * | 1992-10-15 | 1999-09-08 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Novel amino acid derivative |
US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7157277B2 (en) * | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
US7795210B2 (en) * | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
US8008252B2 (en) * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
DE60336555D1 (de) * | 2002-06-21 | 2011-05-12 | Novo Nordisk Healthcare Ag | Pegylierte glykoformen von faktor vii |
ES2420581T3 (es) * | 2003-03-14 | 2013-08-26 | Biogenerix Gmbh | Polímeros solubles en agua ramificados y sus conjugados |
EP1613261A4 (en) * | 2003-04-09 | 2011-01-26 | Novo Nordisk As | INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
MXPA05010773A (es) * | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos. |
ATE540055T1 (de) | 2003-05-09 | 2012-01-15 | Biogenerix Ag | Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
KR20060120141A (ko) * | 2003-11-24 | 2006-11-24 | 네오스 테크놀로지스, 인크. | 글리코페질화 에리트로포이에틴 |
US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
US20080318850A1 (en) * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix |
MXPA06006029A (es) * | 2003-12-03 | 2006-08-23 | Neose Technologies Inc | Factor de estimulacion de colonias de granulocitos modificado por glicopolietilenglicol. |
US7956032B2 (en) * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
WO2005070138A2 (en) * | 2004-01-08 | 2005-08-04 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
US20080300173A1 (en) | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
EP1799249A2 (en) * | 2004-09-10 | 2007-06-27 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
EP1814573B1 (en) | 2004-10-29 | 2016-03-09 | ratiopharm GmbH | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
WO2006074279A1 (en) * | 2005-01-06 | 2006-07-13 | Neose Technologies, Inc. | Glycoconjugation using saccharyl fragments |
JP4951527B2 (ja) * | 2005-01-10 | 2012-06-13 | バイオジェネリックス アーゲー | 糖peg化顆粒球コロニー刺激因子 |
EP1866427A4 (en) * | 2005-03-30 | 2010-09-01 | Novo Nordisk As | MANUFACTURING PROCESS FOR THE PRODUCTION OF CULTIVE PEPTIDES IN CELL LINES OF INSECTS |
EP2386571B1 (en) * | 2005-04-08 | 2016-06-01 | ratiopharm GmbH | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
WO2006127910A2 (en) * | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
EP2975135A1 (en) * | 2005-05-25 | 2016-01-20 | Novo Nordisk A/S | Glycopegylated factor IX |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
CN102719508A (zh) * | 2005-08-19 | 2012-10-10 | 诺和诺德公司 | 糖基聚乙二醇化的因子vii和因子viia |
US20090048440A1 (en) * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
EP2049144B8 (en) * | 2006-07-21 | 2015-02-18 | ratiopharm GmbH | Glycosylation of peptides via o-linked glycosylation sequences |
JP2010505874A (ja) * | 2006-10-03 | 2010-02-25 | ノヴォ ノルディスク アー/エス | ポリペプチドコンジュゲートの精製方法 |
ES2655734T3 (es) * | 2006-10-04 | 2018-02-21 | Novo Nordisk A/S | Glicopéptidos y azúcares pegilados unidos a glicerol |
WO2008073620A2 (en) * | 2006-11-02 | 2008-06-19 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
EP2144923B1 (en) * | 2007-04-03 | 2013-02-13 | BioGeneriX AG | Methods of treatment using glycopegylated g-csf |
US20090053167A1 (en) * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides |
WO2008151258A2 (en) * | 2007-06-04 | 2008-12-11 | Neose Technologies, Inc. | O-linked glycosylation using n-acetylglucosaminyl transferases |
WO2008154639A2 (en) * | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
US8207112B2 (en) * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
EP2242505A4 (en) * | 2008-01-08 | 2012-03-07 | Biogenerix Ag | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES |
CN101965200B (zh) | 2008-02-27 | 2013-06-19 | 诺沃-诺迪斯克有限公司 | 缀合的因子ⅷ分子 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322341A (en) * | 1980-05-13 | 1982-03-30 | Fujisawa Pharmaceutical Co | Peptide, process for preparation thereof and use thereof |
DK156252C (da) * | 1979-07-31 | 1989-12-18 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf |
EP0027260B1 (en) * | 1979-10-11 | 1985-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Peptides, processes for their preparation and pharmaceutical compositions containing them |
GR81332B (fi) * | 1980-12-01 | 1984-12-11 | Fujisawa Pharmaceutical Co | |
US4493794A (en) * | 1980-12-31 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | Peptide, process for preparation thereof and use thereof |
-
1984
- 1984-03-30 US US06/595,169 patent/US4565653A/en not_active Expired - Fee Related
-
1985
- 1985-03-26 PH PH32046A patent/PH21303A/en unknown
- 1985-03-26 EP EP85302065A patent/EP0157572A3/en not_active Withdrawn
- 1985-03-27 ES ES541620A patent/ES8605821A1/es not_active Expired
- 1985-03-28 CA CA000477796A patent/CA1270098A/en not_active Expired - Fee Related
- 1985-03-28 GR GR850783A patent/GR850783B/el unknown
- 1985-03-28 EG EG201/85A patent/EG17928A/xx active
- 1985-03-28 ZA ZA852335A patent/ZA852335B/xx unknown
- 1985-03-28 PT PT80181A patent/PT80181B/pt not_active IP Right Cessation
- 1985-03-28 DD DD85274551A patent/DD239406A5/de not_active IP Right Cessation
- 1985-03-29 FI FI851271A patent/FI851271L/fi not_active Application Discontinuation
- 1985-03-29 NO NO851278A patent/NO851278L/no unknown
- 1985-03-29 HU HU851217A patent/HU198086B/hu unknown
- 1985-03-29 AU AU40523/85A patent/AU552919B2/en not_active Ceased
- 1985-03-29 PL PL25265985A patent/PL252659A1/xx unknown
- 1985-03-29 JP JP60066380A patent/JPS60224699A/ja active Pending
- 1985-03-29 DK DK142485A patent/DK142485A/da not_active Application Discontinuation
- 1985-03-29 NZ NZ211634A patent/NZ211634A/xx unknown
- 1985-03-29 KR KR1019850002106A patent/KR870000372B1/ko not_active IP Right Cessation
- 1985-03-29 IL IL74758A patent/IL74758A/xx unknown
-
1986
- 1986-04-22 AU AU56476/86A patent/AU566460B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR850006939A (ko) | 1985-10-25 |
PL252659A1 (en) | 1985-11-19 |
US4565653A (en) | 1986-01-21 |
KR870000372B1 (ko) | 1987-03-06 |
AU4052385A (en) | 1985-10-03 |
NO851278L (no) | 1985-10-01 |
HUT37443A (en) | 1985-12-28 |
HU198086B (en) | 1989-07-28 |
NZ211634A (en) | 1988-10-28 |
FI851271A0 (fi) | 1985-03-29 |
IL74758A (en) | 1988-06-30 |
CA1270098A (en) | 1990-06-05 |
DD239406A5 (de) | 1986-09-24 |
AU566460B2 (en) | 1987-10-22 |
ES8605821A1 (es) | 1986-04-01 |
PT80181B (en) | 1987-03-20 |
AU5647686A (en) | 1986-09-04 |
DK142485A (da) | 1985-10-01 |
EP0157572A3 (en) | 1987-01-07 |
DK142485D0 (da) | 1985-03-29 |
EP0157572A2 (en) | 1985-10-09 |
PH21303A (en) | 1987-09-28 |
EG17928A (en) | 1991-08-30 |
JPS60224699A (ja) | 1985-11-09 |
GR850783B (fi) | 1985-11-25 |
PT80181A (en) | 1985-04-01 |
IL74758A0 (en) | 1985-06-30 |
ZA852335B (en) | 1986-11-26 |
ES541620A0 (es) | 1986-04-01 |
AU552919B2 (en) | 1986-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3583455D1 (de) | Salbenbase. | |
FI851271L (fi) | Acyltripeptid-immunostimulanser. | |
DE3581430D1 (de) | Detergens. | |
DE3576268D1 (de) | Hoergeraet. | |
ATE41922T1 (de) | Alkylsulfonamidophenylalkylamine. | |
DE3585265D1 (de) | Fibronektinpraeparate. | |
DE3581707D1 (de) | Neigungsmesser. | |
DE3583080D1 (de) | Mikrorechner. | |
FI840024A (fi) | Instaellbart saengbotten. | |
FI841224A (fi) | Uppvaermningsanordning. | |
DE3578421D1 (de) | Glycidyloxydiketone. | |
DE3582060D1 (de) | Homopropargylamine. | |
DE3577708D1 (de) | Diphenylhexafluorpropanabkoemmlinge. | |
DE3584628D1 (de) | Xenocoumacine. | |
FI841334A (fi) | Karda. | |
DE3586085D1 (de) | Antitumor-4-hydroxy-2-zyklopentenonen. | |
DE3579862D1 (de) | Mikrorechner. | |
FI860500A0 (fi) | Haor-, hud- och nagelbehandling. | |
DE3574867D1 (de) | Aminokarnitine. | |
FI843482A (fi) | Regnvattensbrunn. | |
DE3574494D1 (de) | Selbstzerlegerzuender. | |
DE3576291D1 (de) | Entaester. | |
DE3574593D1 (de) | Hexahydroindolizinone. | |
DE3585189D1 (de) | Alpha-d-mannosidase hemmungsmittel. | |
FI840021A (fi) | Tillbringarestaellning. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Owner name: PFIZER INC. |